Cardiometabolic & kidneyRandomised controlled trial

An online, predominantly plant-based, dietary intervention for improving cardiovascular risk: A randomized controlled trial in people with type 2 diabetes

Am Heart JPublished

  • randomized controlled trial
  • Proof-of-concept study

Authors' conclusion

An online plant-based dietary intervention did not significantly reduce HbA1c and resulted in a trend toward a 16% estimated reduction in relative CVD risk. Several secondary outcomes, including dietary components, weight, and LDL-c improved.

Study context

Population
People with T2D on stable medicationrandomized, 48 completing the trial
Participants
49 people
Comparison
12-week, predominantly plant-based online dietary intervention compared to usual diet
Primary endpoint
Coprimary: change in HbA1c and estimated relative CVD risk calculated from change in HbA1c, low-density lipoprotein cholesterol (LDL-c), and systolic blood pressure (SBP)
Follow-up
12 weeks

Primary result

As reported in the abstract

nonsignificant; reduction in plant-based compared to usual diet group
reduction in HbA1c 3 mmol/mol (95% CI −7 to 2)
reduction in plant-based compared to usual diet group
estimated relative cardiovascular disease (CVD) risk reduction 16% (95% CI −29 to 1%)

Secondary outcomes

Outcomeincrease (95% CI)
Plant-based to total protein intake · increased in plant-based compared to usual diet group35% (21–49%)
Outcomedifference (mmHg) (95% CI)
SBP · no effect−3 (−10 to 4)
OutcomeEstimate
Saturated fat intake · decreased in plant-based compared to usual diet groupdecrease 4 energy-percent (95% CI −6 to −1)
Weight · decreased in plant-based compared to usual diet groupdecrease 2.0 kg (95% CI −3.6 to −0.5)
LDL-c · decreased in plant-based compared to usual diet groupdecrease 0.3 mmol/L (95% CI −0.6 to −0.0)

Medication use

Medication use remained stable

Original publication

An online, predominantly plant-based, dietary intervention for improving cardiovascular risk: A randomized controlled trial in people with type 2 diabetes. Am Heart J. Published 2 April 2026. doi:10.1016/j.ahj.2026.107436

Summarised from the published abstract; every number is checked against it